Viewing nowRosuvastatin 5mg Tablet (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
GL Pharm Co., Ltd.

MFDS item code 201904445 · Approved 2019.06.28 · Insurance code 649702250
Improvement of dyslipidemia; slowing of atherosclerosis progression; reduction of cardiovascular disease risk
This medication is used as an adjunct when primary hypercholesterolemia and mixed hyperlipidemia are not controlled by diet and exercise. It reduces LDL cholesterol and total cholesterol levels in pediatric patients with homozygous familial hypercholesterolemia and heterozygous familial hypercholesterolemia in conjunction with dietary therapy, enhancing treatment effectiveness. It is also utilized as an adjunct to dietary therapy in patients with primary dysbetalipoproteinemia. This drug lowers total cholesterol and LDL cholesterol levels, slowing the progression of atherosclerosis and reducing the risks of stroke, myocardial infarction, and endovascular interventions in patients at risk for cardiovascular disease. Overall, it is effective in improving cardiovascular health.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug, and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 mg once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased to a maximum of 20 mg once daily. 3. Older adults: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this drug is contraindicated in some of these patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10–17 years) The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. The safety and efficacy in children under 10 years of age have not been established.
This drug should not be used in certain patients. For example, patients with allergies to this drug, severely impaired liver function, muscle diseases, and those taking certain medications should not take this medication. Women who are pregnant or breastfeeding should not take this medication, and women of childbearing age should use appropriate contraception to prevent pregnancy. Additionally, patients at high risk for muscle disease should avoid high doses. Regular monitoring of liver function tests and muscle-related tests is required. Caution is especially needed for individuals with a history of liver disease or those who consume alcohol heavily. If symptoms such as muscle pain, muscle weakness, or sudden fatigue occur, they should contact a doctor immediately. This drug may interact with certain medications, so anyone taking other medications must inform their healthcare provider, and dosage adjustments or discontinuation may be necessary if taken with specific drugs. Liver or kidney function issues may arise while taking this medication, making regular check-ups necessary, and medical consultation should be sought upon any abnormal symptoms. Dizziness may occur while driving or operating machinery, so caution is warranted. In cases of overdose, there is no specific antidote, so immediate medical attention should be sought for appropriate treatment and examination.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, hives, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, shortness of breath, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), morbilliform drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, appetite loss, abdominal distension, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. The appropriate storage temperature is recommended to be kept at room temperature between 1 degree and 30 degrees. This helps maintain the drug's efficacy over time and ensures safe usage.
Yellow round film-coated tablet
28 tablets / PTP [(14 tablets/PTP x 2 packs)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
GL Pharm Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.